Japan Agency Seeks To Take iPS Discoveries To Development
This article was originally published in PharmAsia News
Executive Summary
Japan's Science & Technology Agency holds the key for some researchers for developing new drugs based on artificial creation of human induced pluripotent stem cells. University researchers in Japan announced eight months ago they had created the iPS cells, but they have no way to get their knowledge to the phase of actually making new drugs and therapy. The JST is attempting to fill the gap with its cell-reprogramming project aimed at fostering the new science. (Click here for more - a subscription may be required